Bannari Amman Sugars cash flow

Latest FY26

Cash from operations: ₹514cr+19.7% on FY25
Capital spending: ₹114cr+51.0% on FY25
Free cash flow: ₹400cr+13.0% on FY25
Cash from financing: −₹161cr−₹369 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	61.1	58.5	57.6	74.0
	—	2.1	15.8	31.6	49.3
	—	−6.5	−1.5	−1.4	−35.3
	—	−0.1	−0.1	−0.1	−0.0
	—	−0.2	−0.2	0.0	0.0
	—	−3.6	−0.1	−0.1	0.0
	—	−11.0	−0.0	−0.9	−0.0
	—	379	123	−36.6	33.5
	—	61.4	108	16.5	200
	—	0.0	0.0	0.0	−65.6
	—	0.0	6.7	13.2	23.3
	—	−0.5	−0.0	1.3	5.0
	—	−0.1	0.0	0.0	0.0
	—	−38.4	0.0	0.0	0.0
	—	−53.8	8.1	−1.7	−5.7
	—	17.0	−0.6	5.9	−5.2
	—	−12.5	−0.9	0.7	14.4
	—	−17.2	−20.4	6.8	35.4
	—	−3.1	−0.4	1.2	3.3
Cash from operating activities
	139	177	162	224	220
	—	374	296	93.9	326
	—	551	459	318	547
	—	37.1	29.2	43.6	44.3
	—	514	430	274	502
Cash from investing activities
	—	114	75.6	141	64.9
	—	5.4	0.7	1.4	0.7
	—	−247	0.0	0.0	0.0
	—	0.0	0.0	0.0	0.2
	—	0.0	0.0	0.0	0.0
	—	0.1	0.1	0.1	0.0
	—	14.7	9.7	9.7	7.8
	—	−341	−65.1	−130	−56.6
Cash from financing activities
	—	0.0	−114	−91.6	83.5
	—	141	222	3.4	463
	—	0.1	0.2	0.2	0.3
	—	—	—	0.1	0.1
	—	3.9	17.6	32.6	50.6
	—	15.7	15.7	15.7	12.5
	—	0.0	−0.0	0.0	0.0
	—	−161	−369	−144	−443
	—	12.1	−5.1	0.7	2.8
	—	12.1	−5.1	0.7	2.8
	—	—	—	6.4	5.7
Reference items
	156	198	210	306	304
	9.3%	10.3%	11.7%	13.8%	12.1%
	400	400	354	133	437
	—	255	0.3	5.5	—
	₹319.00	₹319.00	₹282.23	₹106.16	₹348.79
	9.86×	—	—	—	—
	—	3.48×	4.10×	1.80×	3.50×
	—	37.1	29.2	43.6	44.3
	—	3.9	17.6	32.6	50.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BANARISUG₹3,146.60

Bannari Amman Sugars Limited

· FMCG & Retail

₹ CrorePeersBAJAJHIND DALMIASUG AVADHSUGAR UTTAMSUGAR DHAMPURSUG DWARKESH DBOL MAGADSUGARMcap ₹3,946 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	74.0	57.6	58.5	61.1	—
+ Finance Costs	49.3	31.6	15.8	2.1	—
+ Interest Income	-35.3	-1.4	-1.5	-6.5	—
+ Dividend Income	-0.0	-0.1	-0.1	-0.1	—
+ Unrealised FX (Gain) / Loss	0.0	0.0	-0.2	-0.2	—
+ Other Non-cash Items	0.0	-0.1	-0.1	-3.6	—
+ Other Reconciling Items	-0.0	-0.9	-0.0	-11.0	—
Changes in Working Capital
+ Inventories	33.5	-36.6	123.3	379.4	—
+ Trade Receivables — Current	199.7	16.5	108.3	61.4	—
+ Trade Receivables — Non-current	-65.6	0.0	0.0	0.0	—
+ Other Financial Assets — Current	23.3	13.2	6.7	0.0	—
+ Other Financial Assets — Non-current	5.0	1.3	-0.0	-0.5	—
+ Other Current Assets	0.0	0.0	0.0	-0.1	—
+ Other Non-current Assets	0.0	0.0	0.0	-38.4	—
+ Trade Payables — Current	-5.7	-1.7	8.1	-53.8	—
+ Other Financial Liabilities — Current	-5.2	5.9	-0.6	17.0	—
+ Other Financial Liabilities — Non-current	14.4	0.7	-0.9	-12.5	—
+ Provisions — Current	35.4	6.8	-20.4	-17.2	—
+ Provisions — Non-current	3.3	1.2	-0.4	-3.1	—
Cash from Operating Activities
Profit Before Tax (per I/S)	220.2	223.9	162.3	177.5	138.7
+ Total Adjustments (incl. Working Capital)	326.3	93.9	296.5	373.9	—
Cash from Operations (pre-tax)	546.5	317.8	458.8	551.4	—
+ Income Taxes Paid	44.3	43.6	29.2	37.1	—
Cash from Operating Activities	502.3	274.2	429.6	514.2	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	64.9	141.1	75.6	114.2	—
+ Disp of Fixed Assets	0.7	1.4	0.7	5.4	—
+ Disp of Investment Property	0.0	0.0	0.0	-247.5	—
+ Acq of Biological Assets	0.2	0.0	0.0	0.0	—
+ Disp of Biological Assets	0.0	0.0	0.0	0.0	—
+ Dividends Received — Investing	0.0	0.1	0.1	0.1	—
+ Interest Received — Investing	7.8	9.7	9.7	14.7	—
Cash from Investing Activities	-56.6	-129.9	-65.1	-341.5	—
Cash from Financing Activities
+ Proceeds from Borrowings	83.5	-91.6	-113.5	0.0	—
+ Repayment of Borrowings	462.9	3.4	222.4	140.9	—
+ Payment of Lease Liabilities	0.3	0.2	0.2	0.1	—
+ Payment of Finance Lease Liabilities	0.1	0.1	—	—	—
+ Interest Paid	50.6	32.6	17.6	3.9	—
+ Dividends Paid	12.5	15.7	15.7	15.7	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	-0.0	0.0	—
Cash from Financing Activities	-442.8	-143.6	-369.5	-160.7	—
Net Changes in Cash (pre-FX)	2.8	0.7	-5.1	12.1	—
Net Changes in Cash	2.8	0.7	-5.1	12.1	—
Closing Cash	5.7	6.4	—	—	—
Reference Items
EBITDA	304.2	306.4	210.3	197.7	156.1
EBITDA Margin %	12.05	13.80	11.73	10.31	9.35
Free Cash Flow (CFO − Capex)	437.4	133.1	353.9	400.0	400.0
Free Cash Flow to Equity	—	5.5	0.3	255.2	—
Free Cash Flow per Basic Share	348.79	106.16	282.23	319.00	319.00
Price to Free Cash Flow	—	—	—	—	9.86
Cash Flow to Net Income	3.50	1.80	4.10	3.48	—
Cash Paid for Taxes	44.3	43.6	29.2	37.1	—
Cash Paid for Interest	50.6	32.6	17.6	3.9	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.